GlassScriptPhysician profile
Ashley Bonneau
NPI 1811635329
$3,851.62
in general payments reported to CMS, 2019-2025
20 companies · $458 in 2025
The $458 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $114 · 2023: $2,303 · 2024: $977 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Travel and Lodging: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.49 |
| Travel and Lodging | $1,200.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,579.11 | 2023 | Cvi Contact Lens |
| Abbvie INC. | $429.86 | 2022-2025 | Vuity, Alphagan P, Ozurdex |
| Apellis Pharmaceuticals, INC. | $237.81 | 2023-2024 | Syfovre |
| Astellas Pharma US INC | $180.72 | 2024 | Izervay |
| Glaukos Corporation | $158.89 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $156.25 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $155.74 | 2024-2025 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $142.34 | 2023-2024 | Eylea Hd |
| Sun Pharmaceutical Industries INC. | $136.44 | 2023-2025 | Cequa |
| Alcon Vision LLC | $131.19 | 2025 | Tryptyr |
| Carl Zeiss Meditec, INC. | $108.36 | 2022-2024 | |
| Horizon Therapeutics Plc | $105.36 | 2023 | Tepezza |
| Alimera Sciences, INC. | $101.47 | 2022-2024 | Iluvien, Yutiq |
| Biotissue Holdings INC. | $58.82 | 2022-2024 | |
| Genentech USA, INC. | $49.38 | 2024 | Vabysmo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $43.42 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $21.23 | 2023 | Tyrvaya |
| Coherus Oncology, INC. | $21.10 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.38 | 2023 | |
| Eyepoint US, INC. | $16.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bonneau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.